Queen Square Centre for Neuromuscular Diseases


COVID-19 Vaccination Update

22 December 2020

Following a review of data from those affected by COVID-19 there is no evidence at this time to suggest that COVID-19 either causes or worsens neuropathy or causes GBS. In previous recent, modern vaccination campaigns, any link to neuropathy is very small if at all. For instance, the influenza vaccine is associated with GBS causation in about 1 in a million vaccinations. The risk of serious illness or death from contracting COVID-19 is about 1:1000 and substantially higher in older age groups.